Dojolvi was approved in the US in 2020 and was also launched in Japan earlier this year. Ultragenyx recorded sales of $45 ...

The WuXi agreement gives Fresenius "full strategic flexibility" to choose which biosimilar candidates to develop and gives ...

Hutchmed and AstraZeneca's Orpathys is now under review in Europe and Japan for MET-driven, EGFR-mutated lung cancer, a few ...

As the only dedicated forum convening the global liquid biopsy community, the 11th Liquid Biopsy for Precision Oncology ...

Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid) has been granted an accelerated approval by the FDA as a ...

On 3 and 4 December 2026, Florence will host ISMAI 2026, the International Symposium on Medical AI, organised by the ...

A patient-led initiative for rare disease hereditary haemorrhagic telangiectasia (HHT) has won the inaugural Prix Galien ...

Marcus Evans today announced the Evolution Summit 2027, an invitation-only gathering of senior clinical trial executives, ...

While praising the breadth of its pipeline, AstraZeneca has launched a three-year cost-cutting programme that will aim to ...

Aspen Neuroscience, which is developing stem cell therapies for Parkinson's disease, sold 9.37 million shares, slightly below ...

The Novartis Pavillon in Park South of the Novartis Campus in Basel, Switzerland. Novartis's third-quarter results included a ...

Belén Garijo, who took over the reins of the French pharma group in April, said this morning that Sanofi's "whole ...